Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization.
We examined 82 cases of primary non-small cell lung cancer (NSCLC) for loss of heterozygosity (LOH) at the chromosome 9p21-24 region using 16 microsatellite markers. A total of 52 tumors (63%) displayed LOH, and 25 of these cases displayed LOH for all markers. Two cases had small hemizygous losses confined to the p16 gene and more distal markers, whereas 3 cases had loss proximal to p16 and extended through marker D9S126. This latter region has recently been described as another minimal region of loss at 9p21 in lung cancer. However, homozygous deletion of the p16 gene was observed in 18 of 85 cases, with only 5 cases having large deletions extended into the D9S126 region. Furthermore, we did not observe homozygous deletion at the 9p21 region that excluded the p16 gene. Fluorescence in situ hybridization (FISH) analysis using genomic probes spanning either the p16 or Hel-N1 (located at D9S126) gene was performed in 14 tumors. The results from FISH correlated with the chromosomal mapping data, suggesting that the p16 region is the major target of deletion at chromosome 9p21 in primary NSCLC.
Okami
K
K
Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University, Baltimore, MD 21205-2196, USA.
Cairns
P
P
Westra
W H
WH
Linn
J F
JF
Ahrendt
S A
SA
Wu
L
L
Sidransky
D
D
Jen
J
J
D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics*; D002874:Chromosome Mapping / Q000379:methods*; D002899:Chromosomes, Human, Pair 9; D004273:DNA, Neoplasm / Q000032:analysis / Q000235:genetics*; D005629:Frozen Sections; D017353:Gene Deletion; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D019656:Loss of Heterozygosity; D008175:Lung Neoplasms / Q000235:genetics*; D018895:Microsatellite Repeats
D004273:DNA, Neoplasm